SMT201600372B - Compresse di ulipristal acetato - Google Patents
Compresse di ulipristal acetatoInfo
- Publication number
- SMT201600372B SMT201600372B SM201600372T SM201600372T SMT201600372B SM T201600372 B SMT201600372 B SM T201600372B SM 201600372 T SM201600372 T SM 201600372T SM 201600372 T SM201600372 T SM 201600372T SM T201600372 B SMT201600372 B SM T201600372B
- Authority
- SM
- San Marino
- Prior art keywords
- ulipristal acetate
- acetate tablets
- tablets
- ulipristal
- acetate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/329,865 US8512745B2 (en) | 2008-12-08 | 2008-12-08 | Ulipristal acetate tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
SMT201600372B true SMT201600372B (it) | 2017-01-10 |
Family
ID=41621124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SM201600372T SMT201600372B (it) | 2008-12-08 | 2016-10-13 | Compresse di ulipristal acetato |
Country Status (28)
Country | Link |
---|---|
US (5) | US8512745B2 (it) |
EP (2) | EP3103445A1 (it) |
JP (2) | JP5784502B2 (it) |
KR (1) | KR101733533B1 (it) |
CN (2) | CN105267168A (it) |
AU (1) | AU2009326084B2 (it) |
BR (1) | BRPI0922796A2 (it) |
CA (1) | CA2745084C (it) |
CO (1) | CO6400186A2 (it) |
CY (1) | CY1118099T1 (it) |
DK (1) | DK2365800T3 (it) |
ES (1) | ES2596554T3 (it) |
HK (1) | HK1232134A1 (it) |
HR (1) | HRP20161262T1 (it) |
HU (1) | HUE030762T2 (it) |
IL (1) | IL213247A (it) |
LT (1) | LT2365800T (it) |
MX (1) | MX343358B (it) |
NZ (1) | NZ593498A (it) |
PL (1) | PL2365800T3 (it) |
PT (1) | PT2365800T (it) |
RS (1) | RS55209B1 (it) |
RU (1) | RU2492853C2 (it) |
SI (1) | SI2365800T1 (it) |
SM (1) | SMT201600372B (it) |
UA (1) | UA101863C2 (it) |
WO (1) | WO2010066749A2 (it) |
ZA (1) | ZA201104137B (it) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2615475C3 (de) * | 1976-04-09 | 1984-05-03 | Philips Patentverwaltung Gmbh, 2000 Hamburg | Sonnenkollektor mit einer Abdeckung aus evakuierten Rohren |
US8512745B2 (en) * | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
LT2419108T (lt) | 2009-04-14 | 2016-12-27 | Laboratoire Hra Pharma | Kontracepcijos pagal poreikį būdas |
EP2471537A1 (en) * | 2010-12-30 | 2012-07-04 | PregLem S.A. | Treatment of pain associated with dislocation of basal endometrium |
CN102727457B (zh) * | 2011-04-08 | 2014-05-28 | 华润紫竹药业有限公司 | 稳定的醋酸优力司特制剂 |
FR2987271B1 (fr) | 2012-02-28 | 2017-08-18 | Hra Pharma Lab | Combinaison de modulateurs selectifs du recepteur a la progesterone et d'anti-inflammatoires non steroidiens |
WO2013175009A1 (en) | 2012-05-25 | 2013-11-28 | Laboratoire Hra-Pharma | Ulipristal acetate for prevention and treatment of breast tumors |
FR2997627B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
FR2997628B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone |
FR2999081B1 (fr) * | 2012-12-06 | 2015-02-27 | Hra Pharma Lab | Dispersion solide d'un modulateur selectif du recepteur a la progesterone |
CN103006595B (zh) * | 2012-12-25 | 2018-04-06 | 江苏亚邦爱普森药业有限公司 | 制备醋酸优力司特片的方法 |
CN103006603B (zh) * | 2013-01-11 | 2015-04-15 | 山东创新药物研发有限公司 | 醋酸乌利司他的固体分散体及固体制剂 |
CN103083326A (zh) * | 2013-02-04 | 2013-05-08 | 四川尚锐生物医药有限公司 | 一种醋酸优力司特药物组合物 |
MX2015014199A (es) * | 2013-04-10 | 2016-06-21 | Preglem Sa | Moduladores del receptor de progesterona para usarse en la terapia de fibromas uterinos. |
CN104865215A (zh) * | 2015-05-16 | 2015-08-26 | 南京海纳医药科技有限公司 | 一种醋酸乌利司他片剂及其溶出度测定方法 |
FR3060389B1 (fr) | 2016-12-20 | 2019-05-31 | Laboratoire Hra-Pharma | Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites |
WO2017216637A2 (en) | 2017-08-04 | 2017-12-21 | Alvogen Malta Operations (Row) Ltd | Tablet form including ulipristal acetate and the methods for its preparation |
CN107982230A (zh) * | 2017-12-25 | 2018-05-04 | 郑州泰丰制药有限公司 | 一种醋酸乌利司他分散片及其制备方法 |
CN114137115B (zh) * | 2021-11-26 | 2023-08-04 | 四川尚锐分析检测有限公司 | 一种采用lc-ms法检测血浆中醋酸优力司特及其代谢物的方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
US5084277A (en) * | 1988-08-30 | 1992-01-28 | Greco John C | Vaginal progesterone tablet |
ZA939565B (en) | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for preparing low dose pharmaceutical products. |
US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
HU227198B1 (en) | 2001-11-27 | 2010-10-28 | Richter Gedeon Nyrt | Pharmaceutical composition for emergency contraception containing levonorgestrel |
ES2212912B1 (es) | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
JP2006519255A (ja) | 2003-02-28 | 2006-08-24 | アメリカ合衆国 | 17α−アセトキシ−11β−(4−N,N−ジメチルアミノフェニル)−19−ノルプレグナ−4,9−ジエン−3,20−ジオンの製造方法、その中間体及びそのような中間体の製造方法 |
DE602005014227D1 (de) | 2004-03-10 | 2009-06-10 | Bayer Schering Pharma Ag | Zusammensetzungen aus drospirenon in molekularer dispersion |
CN101166533A (zh) | 2005-04-28 | 2008-04-23 | 惠氏公司 | 微粉化的tanaproget和含有它的组合物 |
DE602006007453D1 (de) * | 2005-04-28 | 2009-08-06 | Wyeth Corp | Zusammensetzungen mit mikronisiertem tanaproget |
US8475838B2 (en) | 2005-06-03 | 2013-07-02 | Sandoz Ag | Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
SI3263112T1 (sl) | 2006-10-24 | 2020-10-30 | Allergan Pharmaceuticals International Limited | Sestavki in metode za zaviranje endometrijskih proliferacij |
CA2674776A1 (en) | 2006-12-20 | 2008-07-03 | Duramed Pharmaceuticals, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
EA200970646A1 (ru) | 2006-12-28 | 2009-12-30 | Репрос Терапьютикс Инк. | Способы и составы для улучшения биодоступности антипрогестинов |
WO2008088935A2 (en) | 2007-01-17 | 2008-07-24 | Repros Therapeutics Inc. | Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
DK2148681T3 (en) | 2007-04-20 | 2016-07-04 | Preglem Sa | Selective progesteronmodulatorer in the treatment of uterine bleeding |
US20090117184A1 (en) | 2007-11-05 | 2009-05-07 | Sabine Fricke | Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception |
US8512745B2 (en) * | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
-
2008
- 2008-12-08 US US12/329,865 patent/US8512745B2/en active Active
-
2009
- 2009-08-12 UA UAA201108556A patent/UA101863C2/uk unknown
- 2009-12-08 CN CN201510648506.8A patent/CN105267168A/zh active Pending
- 2009-12-08 RS RS20160834A patent/RS55209B1/sr unknown
- 2009-12-08 CN CN2009801493094A patent/CN102245173A/zh active Pending
- 2009-12-08 US US13/140,219 patent/US8735380B2/en active Active
- 2009-12-08 AU AU2009326084A patent/AU2009326084B2/en active Active
- 2009-12-08 PT PT97648554T patent/PT2365800T/pt unknown
- 2009-12-08 MX MX2011006106A patent/MX343358B/es active IP Right Grant
- 2009-12-08 NZ NZ593498A patent/NZ593498A/en unknown
- 2009-12-08 LT LTEP09764855.4T patent/LT2365800T/lt unknown
- 2009-12-08 RU RU2011127989/15A patent/RU2492853C2/ru active
- 2009-12-08 HU HUE09764855A patent/HUE030762T2/en unknown
- 2009-12-08 BR BRPI0922796A patent/BRPI0922796A2/pt not_active Application Discontinuation
- 2009-12-08 EP EP16180011.5A patent/EP3103445A1/en not_active Withdrawn
- 2009-12-08 KR KR1020117015784A patent/KR101733533B1/ko active IP Right Grant
- 2009-12-08 CA CA2745084A patent/CA2745084C/en active Active
- 2009-12-08 ES ES09764855.4T patent/ES2596554T3/es active Active
- 2009-12-08 EP EP09764855.4A patent/EP2365800B1/en not_active Revoked
- 2009-12-08 WO PCT/EP2009/066652 patent/WO2010066749A2/en active Application Filing
- 2009-12-08 SI SI200931534A patent/SI2365800T1/sl unknown
- 2009-12-08 PL PL09764855T patent/PL2365800T3/pl unknown
- 2009-12-08 DK DK09764855.4T patent/DK2365800T3/en active
- 2009-12-08 JP JP2011540058A patent/JP5784502B2/ja active Active
-
2011
- 2011-05-31 IL IL213247A patent/IL213247A/en active IP Right Grant
- 2011-06-03 ZA ZA2011/04137A patent/ZA201104137B/en unknown
- 2011-06-29 CO CO11081262A patent/CO6400186A2/es not_active Application Discontinuation
-
2014
- 2014-04-17 US US14/255,426 patent/US20140228335A1/en not_active Abandoned
-
2015
- 2015-01-15 JP JP2015006168A patent/JP6151727B2/ja active Active
-
2016
- 2016-06-17 US US15/185,508 patent/US9844510B2/en active Active
- 2016-10-03 HR HRP20161262TT patent/HRP20161262T1/hr unknown
- 2016-10-13 SM SM201600372T patent/SMT201600372B/it unknown
- 2016-10-17 CY CY20161101034T patent/CY1118099T1/el unknown
-
2017
- 2017-06-09 HK HK17105729.8A patent/HK1232134A1/zh unknown
- 2017-11-09 US US15/808,420 patent/US20180064651A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600372B (it) | Compresse di ulipristal acetato | |
DK2285411T3 (da) | Nikotintabletsammensætninger | |
DK3090730T3 (da) | Tabletter omfattende eltrombopag-olamin | |
DK3097925T3 (da) | Farmaceutisk sammensætning | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
BRPI1004940A2 (pt) | composição farmacêutica | |
BRPI1015939A2 (pt) | composição farmacêutica | |
ITVR20080024A1 (it) | Struttura di tramoggia | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
FR2935592B1 (fr) | Poudrier | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
DE112008003753B8 (de) | Reißverschluss | |
DK2271618T3 (da) | Farmaceutiske forbindelser | |
DK2272763T3 (da) | Blisterpakning-dispensermaskine | |
BR112012003149A2 (pt) | composição farmacêutica | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI0921301A2 (pt) | composição farmacêutica | |
BRPI0909152A2 (pt) | tabletes comprimidos | |
UA17978S (uk) | Тумба декоративна | |
ES1071922Y (es) | Adorno multiusos | |
DOP2009000016A (es) | Composicion farmaceutica | |
ITUD20080017A1 (it) | Filtro reversibile | |
TH105417B (th) | ยาเม็ด | |
UA17225S (uk) | Диван-ліжко | |
UA20335S (uk) | Пігулка |